Protocol summary
-
Study aim
-
Determining the safety of Administration of Adenosine, Lidocaine, and Mg++(ALM) cocktail among Multiple Trauma Patients receiving Massive Transfusion and Admitted to the Resuscitation Room of Shahid Rajaee Trauma Hospital in Shiraz
-
Design
-
a single-center, phase 1 trial , on 17 paitients, without control group
-
Settings and conduct
-
Eligible patients who transferred from the scene of trauma to resuscitation room will be treated with cocktail.
-
Participants/Inclusion and exclusion criteria
-
Eligible patients are between the ages of 16 and 60 who were transferred directly from the scene to the resuscitation room of Shahid Rajaei Trauma Hospital in Shiraz. Inclusion criteria will include patients who are candidates to receive a second bag of packed red blood cells. the paitients with severe underlying diseases (specially severe cardiac and pulmonary diseases and renal failure) ,and those who experienced slash thoracotomy, or if they have penetrating Traumatic brain injury or exposed brain matter. Also paitients with an irregular base ECG will be excluded from trial
-
Intervention groups
-
The cocktail will be started in a group of 4 patients. if safety is confirmed the dose will be increased in next three patients.The ALM combination will be administered as the bolus and maintenance IV fluid. The maximom bolus dose of ALM IV injection consists of 200cc of normal saline,(87mg) of 2% Lidocaine, (6 mg) of adenosine and (30mg) of magnesium sulfate .The maximum dose of drip combination consists of 0.16 mg/kg/hr lidocaine, 0.19 mg/kg/hr Adenosine, and 0.2 mg/kg/hr MgSO4.Every drip component should be injected from separate bottle in 300 cc normal saline .
-
Main outcome variables
-
side effects;reduction in mortality ,hospitalizatin time ,amount of pack cell recieved
General information
-
Reason for update
-
Due to the fact that the patients in the recovery room of the hospital usually receive up to 2 packs of blood and if needed, the rest of the blood is done in the inpatient departments or after transfer for better monitoring of the patients in the recovery room the criteria for inclusion in the study was changed instead of starting from the third pack to the second pack. Also, due to the lack of hypertonic saline, 3% of normal saline will be used in the blous dose.
Also, due to the fact that people aged 16 to 18 are also considered as adult patients in the field of trauma, and due to the high prevalence of trauma incidents requiring transfusion in these people, they can benefit from this study. The minimum age for entering the study is 18 years. changed to 16 years.
Also, considering the priority of investigating the effect of the cocktail on trauma patients receiving blood, and considering that most of the time such patients do not experience a severe drop in blood pressure or an increase in heart rate, and their injury severity criterion score is not necessarily more than 16; The condition of blood pressure below 70 or blood pressure below 90 with a heart rate of more than 108 was removed to enter the study, and the focus will be on patients receiving the second pack and beyond, regardless of pressure or heart rate. Also, the condition of injury severity criterion score of more than 16 to enter the study will be removed.
Many critically ill patients with low blood pressure and heavy bleeding are transferred to the operating room after receiving a blood bag and receive subsequent blood bags in the operating room. These patients also benefit from this study, so patients with a systolic pressure below 80 who receive the first blood bag are also added to the conditions of entering the study
-
Acronym
-
ALMIMTP
-
IRCT registration information
-
IRCT registration number:
IRCT20230707058707N1
Registration date:
2023-12-06, 1402/09/15
Registration timing:
prospective
Last update:
2024-03-17, 1402/12/27
Update count:
4
-
Registration date
-
2023-12-06, 1402/09/15
-
Registrant information
-
-
Recruitment status
-
Recruitment complete
-
Funding source
-
-
Expected recruitment start date
-
2023-12-22, 1402/10/01
-
Expected recruitment end date
-
2024-04-20, 1403/02/01
-
Actual recruitment start date
-
empty
-
Actual recruitment end date
-
empty
-
Trial completion date
-
empty
-
Scientific title
-
Evaluating the safety of Administration of Adenosine, Lidocaine, and Mg(ALM) cocktail among Multiple Trauma Patients receiving Massive Transfusion with dose escalation A phase I, clinical trial
-
Public title
-
Adenosine, lidocaone, and magnasium cocktail in massive transfusion patients
-
Purpose
-
Treatment
-
Inclusion/Exclusion criteria
-
Inclusion criteria:
Candidate to recieve the second pack of packed red blood cell
A candidate to receive the first bag of red blood cells who has a systolic pressure of 80 or lower
Exclusion criteria:
Severe underlying disease specially cardiac, renal, and pulmonary
Paitient with slash thoracotomy
Penetrating brain injury or exposed brain matter
Paitients with irregular base electrocardiogram
-
Age
-
From 16 years old to 60 years old
-
Gender
-
Both
-
Phase
-
1
-
Groups that have been masked
-
No information
-
Sample size
-
Target sample size:
17
-
Randomization (investigator's opinion)
-
N/A
-
Randomization description
-
-
Blinding (investigator's opinion)
-
Not blinded
-
Blinding description
-
-
Placebo
-
Not used
-
Assignment
-
Other
-
Other design features
-
This is a phase 1 clinical trial. The cocktail will be started with the minimum effective dose in a group of 4-5 patients then if the safety of the cocktail is confirmed the cocktail dose will be increased in the next three patients. The whole number of patients will be 17.
Ethics committees
1
-
Ethics committee
-
-
Approval date
-
2023-11-25, 1402/09/04
-
Ethics committee reference number
-
IR.SUMS.REC.1402.395
Health conditions studied
1
-
Description of health condition studied
-
repairfusion injury
-
ICD-10 code
-
-
ICD-10 code description
-
Primary outcomes
1
-
Description
-
mortality
-
Timepoint
-
during hospital admission
-
Method of measurement
-
number of mortality in admited paitients
2
-
Description
-
recovery from trauma
-
Timepoint
-
At time of discharge from hospital
-
Method of measurement
-
duration of hospital admission
3
-
Description
-
amount of recieved blood
-
Timepoint
-
At the end of hospital admission
-
Method of measurement
-
amount of recieved pack cell
4
-
Description
-
amount of hemoglubin rise
-
Timepoint
-
before bolus after bolus and after drip
-
Method of measurement
-
cheking blood hemoglubin
5
-
Description
-
renal function
-
Timepoint
-
before bolus after bolus and after drip
-
Method of measurement
-
checking BUN and Cr
6
-
Description
-
improvement of clinical course
-
Timepoint
-
before bolus after bolus and after drip
-
Method of measurement
-
arterial blood gas
7
-
Description
-
severity of hemolysis
-
Timepoint
-
before bolus after bolus and after drip
-
Method of measurement
-
checking blood lactate dehydrogenase
8
-
Description
-
coagulopathy recovery
-
Timepoint
-
before bolus after bolus and after drip
-
Method of measurement
-
prothrombin time(PT), partial trombopalstin time(PTT), international normalized ratio(INR)
Intervention groups
1
-
Description
-
1st Intervention group: Adenosine lidocaine magnesium combination will be given to 4 eligible patients simultaneously with the second blood bag in two doses of bolus and infusion. If the safety of the cocktail is confirmed by the decision of the research team in the next group, the dose of the drug will be increased in next group. The cocktail dosage in first 4 patienst is as follows: the bolus dose consists of 200 cc of normal saline, 4 mg of adenosine (injected in one to two seconds with 20 cc of normal saline), 20 mg of lidocaine, 30 mg of magnesium sulfate. These compounds will be injected separately. After injecting the bolus dose, the infusion dose will be injected within 4 hours. The infusion dose will include 0.08 mg/kg/hour lidocaine, 0.09 mg/kg/hour adenosine and 0.2 mg/kg/hour magnesium. Each of these drugs will be injected in 300 cc of normal saline.
-
Category
-
Treatment - Drugs
2
-
Description
-
2end Intervention group: If the safety of the drug is confirmed in the previous stage, in this stage the dosage of the drugs will be slightly increased with the same implementation method as the previous group, which this time will be done on 5 patients. The cocktail dosage in this group is as follows: the bolus dose consists of 200 cc of normal saline, 6 mg of adenosine (injected in one to two seconds with 20 cc of normal saline), 40 mg of lidocaine, 30 mg of magnesium sulfate(Magnesium sulfate calculated by the clinical pharmacologist is much lower than the minimum effective dose in the clinic, so it does not need to gradually increase the dose). These compounds will be injected separately. After injecting the bolus dose, the infusion dose will be injected within 4 hours. The infusion dose will include 0.1 mg/kg/hour lidocaine, 0.12 mg/kg/hour adenosine and 0.2 mg/kg/hour magnesium. Each of these drugs will be injected in 300 cc of normal saline.
-
Category
-
Treatment - Drugs
3
-
Description
-
3rd Intervention group: If the safety of the drug is confirmed in the previous stage, in this stage the dosage of the drugs will be slightly increased with the same implementation method as the previous group, which this time will be done on 4 patients. The cocktail dosage in this group is as follows: the bolus dose consists of 200 cc of normal saline, 9 mg of adenosine (injected in one to two seconds with 20 cc of normal saline), 60 mg of lidocaine, 30 mg of magnesium sulfate(Magnesium sulfate calculated by the clinical pharmacologist is much lower than the minimum effective dose in the clinic, so it does not need to gradually increase the dose). These compounds will be injected separately. After injecting the bolus dose, the infusion dose will be injected within 4 hours. The infusion dose will include 0.13 mg/kg/hour lidocaine, 0.14 mg/kg/hour adenosine and 0.2 mg/kg/hour magnesium. Each of these drugs will be injected in 300 cc of normal saline.
-
Category
-
Treatment - Drugs
4
-
Description
-
4th Intervention group: If the safety of the drug is confirmed in the previous stage, in this stage the dosage of the drugs will be slightly increased with the same implementation method as the previous group, which this time will be done on 4 patients. The cocktail dosage in this group is as follows: the bolus dose consists of 200 cc of normal saline, 12 mg of adenosine (injected in one to two seconds with 20 cc of normal saline), 87 mg of lidocaine, 30 mg of magnesium sulfate(Magnesium sulfate calculated by the clinical pharmacologist is much lower than the minimum effective dose in the clinic, so it does not need to gradually increase the dose). These compounds will be injected separately. After injecting the bolus dose, the infusion dose will be injected within 4 hours. The infusion dose will include 0.16 mg/kg/hour lidocaine, 0.16 mg/kg/hour adenosine and 0.2 mg/kg/hour magnesium. Each of these drugs will be injected in 300 cc of normal saline.
-
Category
-
Treatment - Drugs
1
-
Sponsor
-
-
Grant name
-
-
Grant code / Reference number
-
-
Is the source of funding the same sponsor organization/entity?
-
Yes
-
Title of funding source
-
Shiraz University of Medical Sciences
-
Proportion provided by this source
-
100
-
Public or private sector
-
Public
-
Domestic or foreign origin
-
Domestic
-
Category of foreign source of funding
-
empty
-
Country of origin
-
-
Type of organization providing the funding
-
Academic
Sharing plan
-
Deidentified Individual Participant Data Set (IPD)
-
Undecided - It is not yet known if there will be a plan to make this available
-
Study Protocol
-
Undecided - It is not yet known if there will be a plan to make this available
-
Statistical Analysis Plan
-
Undecided - It is not yet known if there will be a plan to make this available
-
Informed Consent Form
-
Undecided - It is not yet known if there will be a plan to make this available
-
Clinical Study Report
-
Undecided - It is not yet known if there will be a plan to make this available
-
Analytic Code
-
Undecided - It is not yet known if there will be a plan to make this available
-
Data Dictionary
-
Undecided - It is not yet known if there will be a plan to make this available